Product Reports Resources Pricing Login Book a demo

Unchained Labs

Biotech & Life Sciences · Pleasanton, United States · Founded 2014

Helping biologics researchers break free from tools that just don’t cut it MoreLess

Unchained Labs is a life sciences company that specializes in providing innovative tools and technologies designed to address complex research and development challenges. The company serves scientists and researchers in the life sciences sector, offering solutions that enhance the efficiency and accuracy of their work. Operating in the global life sciences market, Unchained Labs focuses on developing automated instrumentation and consumables that streamline workflows and improve the precision of protein quantification and other critical research tasks. The business model revolves around the sale of high-tech instruments and consumables, as well as providing ongoing support and services to ensure optimal performance and customer satisfaction. Revenue is generated through direct sales, service contracts, and consumable sales, catering primarily to pharmaceutical companies, biotech firms, and academic research institutions.

Keywords: life sciences, protein quantification, automated workflows, research tools, biotech, pharmaceutical, consumables, instrumentation, R&D, precision.

Company overview

Unchained Labs company information

The essential company record, classifications and operating signals in one place.

Status
Acquired
Founded
2014
Headquarters
Pleasanton, United States
Employees
216
Open positions
7
Dealroom signal
66.4
Investment activity
4 companies · latest Jul 2023
Capital deployed
Preferred round
ACQUISITION
client focusb2bsub industryBioTechnologysectorAccountingindustryHealthsectorBiotechnologysectorOncologysectorCampingsectorDNAsectorSurgerysectorNeurologysectorGenetics and genomicssectorNon-Invasive medical devices and treatmentssectorProduct ResearchsectorGenome Engineering

Valuation & funding

Unchained Labs funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
DEBTDebt Aug 2021 $155M Midcap Financial · Golub Capital
ACQUISITIONOther financing Apr 2021 $435M $435M The Carlyle Group
DEBTDebt May 2019 $50M Standard Treasury
SERIES DOther financing Mar 2018 $17M $68M Canaan · TPG Biotech · Novo Ventures
SERIES COther financing Jun 2017 $13M $52M Novo Ventures · Canaan · TPG Biotech
SERIES BOther financing Feb 2016 TPG Biotech · Novo Ventures · Canaan
SERIES AOther financing Feb 2015 TPG Biotech · Canaan · Novo Ventures · TPG
Showing 7 recorded eventsUnlock the complete deal history →

Growth signals

Unchained Labs website traffic

Latest recorded traffic for Unchained Labs is 27K monthly website visits, up 12.5% over the last three months. Unchained Labs's team declined 0.5% over the past year.

Latest monthly visits27K 3-month web change+12.5% 1-year team growth-0.5%
Monthly website visits117 observations · Apr 2016–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Hiring

Open positions at Unchained Labs

Current openings linked to this company in Dealroom.

1 distinct opening shownExplore hiring signals →

Comparisons

Unchained Labs compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

Unchained Labs's talent

Book a demo to see the people
Team profiled 21 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

8 investors on Unchained Labs's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Series A 4 investors entered at this stage
Canaan
TPG
TPG Biotech
Novo Ventures
Series B+ 3 investors entered at this stage
Standard Treasury
Midcap Financial
Golub Capital
Other known 1 additional known investor
The Carlyle Group

Global footprint

Where Unchained Labs has talent and traffic

Workforce by country
9 countries with
team presence
🇺🇸 United States60.8%
🇬🇧 United Kingdom14.5%
🇧🇪 Belgium7.8%
🇯🇵 Japan6%
🇨🇳 China5.4%
Top 5 of 9 shown

In the news

Latest news about Unchained Labs

Recent press, funding announcements, and product moves mentioning Unchained Labs — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Unchained Labs

An AI-synthesized read of the highest-engagement posts about Unchained Labs on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Unchained Labs’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.